Zentalis Pharmaceuticals

At Zentalis, we are working on clinically distinctive medications that target essential cancer pathways with the potential to meet significant medical needs for cancer patients. Over the Company's initial five years, we have successfully progressed three compounds into clinical trials, all of which were internally developed using our integrated discovery engine's extensive chemistry capabilities.